Coexist or eliminate? Antibody-based functional silencing versus eradication in gut microbiome- targeted therapy

Sherif A. El-Kafrawy, Ayman T. Abbas, Abdelrahman S. El-Kafrawy, Mai M. El-Daly, Esam I. Azhar

Open source

DOI
10.3389/fimmu.2026.1903103
Published
2026-07-15
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1903103,
  title = {Coexist or eliminate? Antibody-based functional silencing versus eradication in gut microbiome- targeted therapy},
  author = {Sherif A. El-Kafrawy and Ayman T. Abbas and Abdelrahman S. El-Kafrawy and Mai M. El-Daly and Esam I. Azhar},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1903103},
  url = {https://doi.org/10.3389/fimmu.2026.1903103}
}

RIS

TY  - JOUR
TI  - Coexist or eliminate? Antibody-based functional silencing versus eradication in gut microbiome- targeted therapy
AU  - Sherif A. El-Kafrawy
AU  - Ayman T. Abbas
AU  - Abdelrahman S. El-Kafrawy
AU  - Mai M. El-Daly
AU  - Esam I. Azhar
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1903103
UR  - https://doi.org/10.3389/fimmu.2026.1903103
ER  - 

APA

El-Kafrawy, S. A., Abbas, A. T., El-Kafrawy, A. S., El-Daly, M. M., & Azhar, E. I. (2026). Coexist or eliminate? Antibody-based functional silencing versus eradication in gut microbiome- targeted therapy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1903103

Source records